Last updated on November 2018

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of mirikizumab in participants with moderate to severe plaque psoriasis.

Clinical Study Identifier: NCT03482011

Contact Investigators or Research Sites near you

Start Over

Francisco A Kerdel

Florida Academic Dermatology Centers
Coral Gables, FL United States
  Connect »